Filter
5488
Filtered Results: 5488
Text search:
drug
development
Featured
Recommendations
474
New Publications
1477
Language
Document type
No document type
3371
Studies & Reports
856
Guidelines
658
Manuals
225
Strategic & Response Plan
167
Fact sheets
76
Training Material
73
Situation Updates
20
Infographics
14
Resource Platforms
10
Brochures
8
Online Courses
7
Dashboards/Maps
1
App
1
Videos
1
Countries / Regions
India
313
Global
190
Kenya
175
South Africa
133
Ethiopia
130
Uganda
126
Nigeria
117
Western and Central Europe
110
Tanzania
102
Nepal
101
Sierra Leone
92
Liberia
89
Zambia
87
Malawi
85
Myanmar / Burma
80
Latin America and the Carribbean
74
Ghana
73
Africa
72
Bangladesh
71
Rwanda
65
Ukraine
57
Eastern Europe
57
Philippines
52
Namibia
52
Zimbabwe
44
Asia
41
South–East Asia Region
40
Cambodia
39
Russia
38
Lesotho
37
Indonesia
32
Botswana
29
Congo, Democratic Republic of
28
Mozambique
26
Syria
23
Eswatini/ Swaziland
23
Senegal
21
Burkina Faso
20
Colombia
19
Germany
19
Brazil
17
South Sudan
17
Cameroon
16
East and Southern Africa
16
USA
15
West and Central Africa
15
Haiti
14
Middle East and North Africa
14
Tajikistan
13
Albania
12
Venezuela
12
Pakistan
11
Thailand
10
China
10
Guinea
10
Afghanistan
9
Eastern Europe and Central Asia
9
Vietnam
9
Georgia
9
Argentina
8
Sudan
8
Armenia
7
Paraguay
7
Moldova
7
Mexico
6
Laos
6
Western Pacific Region
6
North America
6
Yemen
6
North Macedonia
5
Benin
5
Peru
5
Lebanon
5
Sri Lanka
5
Central African Republic
5
Iraq
5
El Salvador
4
Jordan
4
Jamaica
4
United Kingdom
4
Bhutan
4
Somalia
4
Madagascar
4
Timor Leste/ East Timor
3
Turkey
3
Iran
3
Fiji
3
Kyrgyzstan
3
Côte d’Ivoire / Ivory Coast
3
Bolivia
3
Papua New Guinea
3
Palestine
3
Mali
3
Angola
3
Libya
3
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Estonia
2
Uzbekistan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Saudi Arabia
2
France
2
Portugal
2
Spain
2
Belarus
2
Southern Africa
2
Poland
2
Honduras
2
Ecuador
2
North Korea
1
Switzerland
1
Australia
1
Gambia
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Nicaragua
1
Egypt
1
Romania
1
Greece
1
Chad
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2139
Clinical Guidelines
487
Public Health
276
Women & Child Health
214
Key Resources
155
Capacity Building
77
Pharmacy & Technologies
62
Annual Report MEDBOX
1
Toolboxes
HIV
620
Mental Health
549
TB
524
AMR
287
NTDs
238
COVID-19
207
Pharmacy
161
NCDs
117
Caregiver
108
Rapid Response
91
Ebola & Marburg
81
Planetary Health
78
Refugee
70
Disability
65
Global Health Education
61
Conflict
58
Health Financing Toolbox
50
Polio
22
Natural Hazards
21
Specific Hazards
16
Cholera
16
Zika
16
Social Ethics
14
Malaria
12
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a ...
Here you can find online courses on drug development, Pharmacology of Antibacterial Agents, pharmaceutical devices, etc.
Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030 (“the road map”) sets explicit targets for the elimination of onchocerciasis by 2030, including eliminating the need for mass drug administration (MDA) of ivermectin in at least...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
Antimicrobial agents like antibiotics are essential to treat some human and animal diseases. Microbes, such as bacteria, can develop resistance to antimicrobials meaning that a drug such as an antibiotic is no longer effective in treating the infection. The development of resistance is caused by the...
The Global status report on alcohol and health and treatment of substance use disorders presents a comprehensive overview of alcohol consumption, alcohol-related harm and policy responses as well as treatment capacities for alcohol and drug use disorders worldwide. The report is based on data collec...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
This Situation Update describes events occurring in Bilin Township, Thaton District during the period between July and October 2017, including healthcare, education, development projects and drug issues.
Interactive Graphic.This interactive graphic covering our current knowledge of the Ebola virus and the history of disease outbreaks has now been updated with information on convalescent therapies and on drug and vaccine developmen
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Human African Trypanosomiasis (HAT, sleeping sickness) and Animal African Trypanosomiasis (AAT) are neglected tropical diseases generally caused by the same etiological agent, Trypanosoma brucei. Despite important advances in the reduction or disappearance of HAT cases, AAT represents a risky reserv...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
Cutaneous Leishmaniasis (CL) is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can lead to isolation and psychosocial pathologies due to social stigma, and its occurrence is often...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...
HIV infection, due to the immunosuppressant that leads, nowadays constitutes an aggravating factor of endemic tuberculosis. Tuberculosis remains a huge burden to human health, even in the early 21st century. The situation is deteriorating in many countries, particularly because of the synergy with t...
Chikungunya virus (CHIKV) is currently one of the most relevant arboviruses to public health. It is a member of the Togaviridae family and alphavirus genus and causes an arthritogenic disease known as chikungunya fever (CHIKF). It is characterized by a multifaceted disease, which is distinguished fr...
In the face of rapid increases in the number of hospitalizations due to COVID-19 in Latin America and the Caribbean, coupled with shortages of human and material resources, including medical equipment and gases, there is a need to redesign models of care in the Region to optimize available resources...
